Doximity Inc (DOCS) Data Analysis Shows Increased Engagement Among Physicians - Jefferies
Tweet Send to a Friend
Jefferies analyst Glen Santangelo reiterated a Buy rating and $78.00 price target on Doximity Inc (NYSE: DOCS) after analyzing 1Q22 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
